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The current issue of the Journal of Midlife Health will be the last issue of our tenure spanning over 2 years of both Dr. Neelam Aggarwal and me, as chief editors of the Journal of Midlife Health.

As we all know that with increased expectancy of life, a female is spending nearly one-third of her life in menopause. Hence, during this postreproductive period, a woman needs preventive health care to prevent and contain noncommunicable diseases such as cancer, cardiovascular diseases, osteoporosis, and neurological disorders.

The article on association of dyslipidemia increased insulin resistance, and serum CA 15-3 with increased risk of breast cancer (BC) highlights that BC is the most common cancer affecting female individuals in the world. Although in India, incidence is significantly lower than in western countries. With an annual incidence of approximately 144,000 cases, BC has now become the most common cancer affecting female individuals in urban India.

In the past few years, extensive efforts have been dedicated to understanding the relationship between dyslipidemia, insulin resistance, type 2 diabetes mellitus, metabolic syndrome, and BC risk. This study suggests that dyslipidemia and disturbed glucose metabolism are correlated with BC and supports the hypothesis that total cholesterol, low-density lipoprotein cholesterol, triglycerides, and serum glucose are important risk factors in the development of BC. Hence, there is a need to reinforce the importance of controlling these risk factors by lifestyle modification such as diet, exercise, yoga, meditation, and medication whenever or wherever necessary.

"Coming together is a beginning, keeping together is progress, working together is success" (Henry Ford) -- holds good for both Dr. Neelam and me. We both have enjoyed working together and have been able to take JMH to further level by its accreditation in Scopus, though we still have a long way to go.

We would like to take this opportunity to profusely thank our editorial board, the peer reviewers, the authors, governing council of the last 2 years, Ms. Arshia from the IMS office and the entire staff of Medknow especially Mr. Sandeep Chugh. We welcome and congratulate the new team of chief editors, Dr. Annil Mahajan and Dr. Ranu Patni, with the hope that they shall raise the standards of JMH to even more heights.
